Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets

2 weeks ago 9

Galapagos NV (NASDAQ:GLPG) is 1 of the

7 Fastest Growing European Stocks to Invest In. On March 31, 2026, Galapagos NV (NASDAQ:GLPG) announced a binding statement with Gilead Sciences (NASDAQ:GILD) related to Gilead’s planned acquisition of Ouro Medicines, a U.S.-based biotech focused connected T compartment engager therapies for autoimmune diseases. The woody includes entree to Ouro’s clinical-stage plus gamgertamig, a BCMAxCD3 T compartment engager, on with further preclinical programs. Under the agreement, Galapagos volition get licenses to cardinal intelligence property, presume definite improvement responsibilities, and summation operational assets including facilities and personnel, efficaciously establishing an operating concern tied to the programs. The model besides allows Galapagos to deploy astatine slightest $500M of its currency independently, including up to $150M for imaginable stock buybacks.

Gamgertamig has received Fast Track and Orphan Drug Designation from the FDA for AIHA and ITP and is expected to participate registrational studies arsenic aboriginal arsenic 2027. Galapagos volition money early-stage development, portion later-stage costs volition beryllium shared with Gilead, which volition pb planetary commercialization extracurricular definite territories. The institution is besides eligible for milestone payments and tiered royalties ranging from 20% to 23% connected nett sales.

Galapagos NV (GLPG) Signs Agreement with Gilead connected  Ouro Medicines Assets

Galapagos NV (GLPG) Signs Agreement with Gilead connected Ouro Medicines Assets

Copyright: zneb076 / 123RF Stock Photo

On March 26, 2026, Galapagos NV (NASDAQ:GLPG) besides announced the projected assignment of Gino Santini arsenic a non-executive autarkic manager and aboriginal seat of the board, taxable to shareholder support astatine its April 28 yearly meeting.

Galapagos NV (NASDAQ:GLPG) develops therapies focused connected oncology and immunology.

While we admit the imaginable of GLPG arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article